Advertisement

Topics

Epigenomics Incorporated Company Profile

12:49 EST 17th November 2017 | BioPortfolio

Epigenomics is a transatlantic biotechnology company with headquarters in Berlin, Germany and its wholly owned subsidiary in Seattle, Washington, USA, pioneering tomorrow´s personalized medicines. By detecting DNA methylation patterns, the "on" and "off" signs for genes, Epigenomics can create a digitized readout (Digital Phenotype®) for each tissue. The comparison of healthy and sick tissue enables an exact diagnosis of disease at a very early stage and opens up new therapeutic opportunities. The combination of diagnosis and therapy, based on this epigenetic information and our robust proprietary technology, is leading the way to improving patients´ quality of life. Epigenomics is the world´s first and only company focusing exclusively on DNA methylation and its importance in the post-genomic age and is supported by the world´s premier network of academic researchers and clinicians with expertise in the field of cancer and DNA methylation.

Location

Suite 300, 1000 Seneca Street
Seattle
Washington
98101
United States of America

Contact

Phone: +1-206-883-2900
Fax: +1-206-254-9151
Email: contact@us.epigenomics.com


News Articles [48 Associated News Articles listed on BioPortfolio]

Epigenomics: Es wird spannend

Trotz der aktuellen Gewinnwarnung von Epigenomics wird es keine Änderungen an den Konditionen der Übernahmeofferte für Epigenomics geben. Die entsprechende Frist für mögliche Veränderungen ist a...

Epigenomics-Aktie stürzt ab: Übernahme gescheitert - und jetzt?

Die Übernahme der Biotech-Gesellschaft Epigenomics durch die Summit Hero Holding ist geplatzt: Mit lediglich 62,13 Prozent wurde die Annahmequote von 75 Prozent deutlich verfehlt. Die Epigenomics-A.....

Epigenomics vor ungewisser Zukunft - Aktien festhalten!

Die Papiere von Epigenomics (WKN: A11QW5) stürzten gestern um -20% ab. Das Unternehmen veröffentlichte die obligatorische Verlustanzeige, nachdem ein Verlust von mehr als der Hälfte des Grundkapit....

DGAP-Adhoc: Epigenomics AG erhöht Kapital im Rahmen einer Privatplatzierung von neuen Aktien (deutsch)

Epigenomics AG erhöht Kapital im Rahmen einer Privatplatzierung von neuen Aktien DGAP-Ad-hoc: Epigenomics AG / Schlagwort(e): Kapitalerhöhung Epigenomics AG erhöht Kapital im Rahmen einer Privatpl....

Epigenomics: Noch eine Hürde bis zum Aufwärtsgalopp!

Liebe Leser, Epigenomics könnte zu einer der großen Überraschungen der nächsten Wochen werden. Die Aktie sattelte nun über 3 % auf und macht sich auf den Weg, nunmehr die 5-Euro-Grenze zu überwi...

Epigenomics: Kommt die Aktie jetzt wieder zurück?

Kommentar von Johannes WeberLiebe Leser, durch die Ausgabe einer Wandelschuldverschreibung im Wert von nominal 7,1 Mio. Euro hat sich das Biotechunternehmen Epigenomics neues Kapital beschafft. Das...

Epigenomics besorgt sich frisches Geld

Epigenomics hat eine Kapitalerhöhung durchgeführt. Ausgegeben werden 1,278 Millionen Aktien. Das Bezugsrecht der Altaktionäre ist ausgeschlossen. Die Papiere sind im Rahmen einer Privatplatzierung ...

Epigenomics muss Prognose für 2017 reduzieren

In den USA entwickeln sich die Geschäfte von Epigenomics mit dem neu zugelassenen Darmkrebstest Epi proColon langsamer als erwartet. Als Folge daraus reduziert die Gesellschaft ihre Prognose für da....

PubMed Articles [24 Associated PubMed Articles listed on BioPortfolio]

Looking Back: Epigenomics.

Our understanding of how changes in epigenomics facilitate reprogramming and lineage specification has grown extensively over the last decade. For our tenth anniversary, we asked authors who cited a s...

Accurate and reproducible functional maps in 127 human cell types via 2D genome segmentation.

The Roadmap Epigenomics Consortium has published whole-genome functional annotation maps in 127 human cell types by integrating data from studies of multiple epigenetic marks. These maps have been wid...

The gymnastics of epigenomics in rice.

Epigenomics is represented by the high-throughput investigations of genome-wide epigenetic alterations, which ultimately dictate genomic, transcriptomic, proteomic and metabolomic dynamism. Rice has b...

The influence of an epigenetics diet on the cancer epigenome.

Unique aspects of the epigenetic code in the brain.

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay

Epigenomics is developing a colon cancer screening assay based on differential methylation of specific CpG sites for the detection of early stage disease. A genome-wide methylation analysi...

Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study

Millions of women suffer from overactive bladder, and the changes in bladder function affect their quality of life. The study team believes that it needs to be better understand why women ...

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

Prospective evaluation of the circulating cell-free DNA-based epigenetic biomarker (mSEPT9) through a cross-sectional biomarker phase II design. The aim of the SEPT9-CROSS study is to asse...

Companies [43 Associated Companies listed on BioPortfolio]

Epigenomics Incorporated

Epigenomics is a transatlantic biotechnology company with headquarters in Berlin, Germany and its wholly owned subsidiary in Seattle, Washington, USA, pioneering tomorrow´s personalized medicines. By...

Epigenomics AG

Epigenomics is a transatlantic biotechnology company with headquarters in Berlin, Germany and its wholly owned subsidiary in Seattle, Washington, USA, pioneering tomorrow´s personalized medicines. By...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

GNS Healthcare and Global Genomics Group

G3 is a global leader in pan-omics and investigates biological networks that lead to the development of disease to identify novel biomarkers and therapeutic targets. G3 combines p...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

More Information about "Epigenomics Incorporated" on BioPortfolio

We have published hundreds of Epigenomics Incorporated news stories on BioPortfolio along with dozens of Epigenomics Incorporated Clinical Trials and PubMed Articles about Epigenomics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Epigenomics Incorporated Companies in our database. You can also find out about relevant Epigenomics Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record